
Dr. Brian Wolpin
Dr. Brian Wolpin is the director of the Pancreatic Cancer Research Center at Dana-Farber Cancer Institute in Boston, contributing to the development of daraxonrasib and emphasizing its potential to change the landscape of pancreatic cancer treatment.
Power1,429
Reach32,918
Country presence
Recent news mentions
Dr. Brian Wolpin, director of the pancreatic cancer research center at Dana-Farber Cancer Institute, explained the challenges of treating the KRAS mutation.
"לא רואים דברים כאלה": הקהל הריע לתרופה הזוידיעות אחרונות (Yedioth Ahronoth / ynet)·
Israel· 2026-06-01







